Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies Antibody Persistence and Booster Response
NCT01173302Phase 4Unknown
- Sponsor
- Peking University People's Hospital
- Start
- May 2010
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of SPEEDA + TRCS SPEEDA in rabies, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
SPEEDA + TRCS SPEEDA
03
Conditions
rabies
Beyond the preview
Go deeper on NCT01173302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173302.